Chicago Equity Partners’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
GGHC
BCM
EAM
Chicago Equity Partners's TNDM Position: Q1 2020 in Review
Chicago Equity Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2020, closing a stake of 14,430 shares — an estimated $860K sold.
Chicago Equity Partners first reported a position in TNDM in Q4 2018 and held it in 5 quarters. The position peaked at $2.8M in Q2 2019. 279 funds tracked by Wall St. Rank hold TNDM as of Q1 2020.
- Chicago Equity Partners reported no remaining Tandem Diabetes Care position as of Q1 2020 after selling out during the quarter.
- Chicago Equity Partners sold 14,430 Tandem Diabetes Care shares in Q1 2020, an estimated $860K.
- Chicago Equity Partners first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 5 quarters.
- Chicago Equity Partners's Tandem Diabetes Care position peaked at $2.8M in Q2 2019.
- 279 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2020.
Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.